Psychosocial Stressor
7
2
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption
Feasibility of Technology-Based SSIP in Prostate Cancer Patients
Severe Asthma, MepolizumaB and Affect: SAMBA Study
Psychosocial Intervention in Assisted Reproduction Treatments
Optimized Psycho-oncological Care Through an Interdisciplinary Care Algorithm
Breaking Potentially Bad News in Lung Cancer Workup: Telephone Versus In-person Breaking of Final Diagnosis